Brief: Otsuka, Lundbeck�s Abilify Maintena approved in EU
21/11/2013 07:05
COPENHAGEN, Nov 21 (Reuters) - Danish pharmaceutical company H. Lundbeck A/S LUN.CO said on Thursday: * Once-monthly Abilify Maintena, which is developed in partnership with Japan's Otsuka 4768.T 4578.T , has been approved by the European Commision for maintenance treatment of schizophrenia in adult patients stabilized with oral aripiprazole ((Copenhagen newsroom, tel: +45 33969649, e-mail: copenhagen.newsroom@thomsonreuters.com)) ((For more news, double-click on LUN.CO ))